Cancer Research
Shaping the Future of Cancer Care
At the Providence Swedish Cancer Institute, research is not just what we do — it’s how we transform what’s possible in cancer care. As one of the most active clinical trial centers in the western United States, we give patients early access to breakthrough therapies, often years before they’re widely available.
Striving to Deliver Treatment Advancements Today
Every study we lead is driven by a single purpose: to push the boundaries of treatment, prevention, and discovery so that patients and families have more options, more hope, and better outcomes. With more than 200 active clinical trials and a robust portfolio of studies, the Providence Swedish Cancer Institute is a national leader in advancing cancer research. Our teams work across disciplines — from immunotherapy and cellular therapies to early detection, genomics, and quality-of-life research — bringing cutting-edge science directly to the patients who need it most, today.
With our strong research infrastructure and deep commitment to innovation, we can open trials faster than most academic centers, often serving as the first site in the Pacific Northwest or even the world to offer next-generation therapies. Every advancement we pursue reflects our belief that better treatments, earlier detection, and smarter prevention are not just possibilities for the future — they are promises we’re working to deliver today.
Research by the Numbers
Our research programs drive innovation across early detection, prevention, precision medicine, and supportive care. Through multidisciplinary collaboration, we work to transform cancer care at every stage.
With more than 200 active trials, we give patients early access to groundbreaking therapies that aren’t yet widely available.
We strive to open clinical trials in less than 100 days, sometimes sooner with our Fast Track process.
Our clinical trial portfolio spans a wide range of cancer types and treatments, including select first-in-human studies.
Paul G. Allen Research Center
The Paul G. Allen Research Center at the Providence Swedish Cancer Institute is a leader in cancer discovery, innovation, and next-generation research. Through pioneering projects and collaborations, the center is helping accelerate breakthroughs that bring the latest scientific advances directly to patients.
News & Info From Our Experts



